<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="ro">
	<id>https://wiki.tradeville.ro/index.php?action=history&amp;feed=atom&amp;title=Milestone_Pharmaceuticals_Inc.</id>
	<title>Milestone Pharmaceuticals Inc. - Revizia istoricului</title>
	<link rel="self" type="application/atom+xml" href="https://wiki.tradeville.ro/index.php?action=history&amp;feed=atom&amp;title=Milestone_Pharmaceuticals_Inc."/>
	<link rel="alternate" type="text/html" href="https://wiki.tradeville.ro/index.php?title=Milestone_Pharmaceuticals_Inc.&amp;action=history"/>
	<updated>2026-04-06T00:47:25Z</updated>
	<subtitle>Istoricul versiunilor pentru această pagină din wiki</subtitle>
	<generator>MediaWiki 1.39.2</generator>
	<entry>
		<id>https://wiki.tradeville.ro/index.php?title=Milestone_Pharmaceuticals_Inc.&amp;diff=430377&amp;oldid=prev</id>
		<title>Admin: Pagină nouă: Pagina dedicata companiei Milestone Pharmaceuticals Inc. listata cu simbolul US.MIST  ==Descriere companie== Milestone Pharmaceuticals Inc. (https://milestonepharma.com/) is a biopharmaceutical company. The Company is focused on the development and commercialization of cardiovascular medicines. Milestone’s lead product candidate is etripamil. The etripamil is a novel, potent and short-acting calcium channel blocker that has been designed rapid-onset nasal spray, which is se...</title>
		<link rel="alternate" type="text/html" href="https://wiki.tradeville.ro/index.php?title=Milestone_Pharmaceuticals_Inc.&amp;diff=430377&amp;oldid=prev"/>
		<updated>2024-09-18T18:12:41Z</updated>

		<summary type="html">&lt;p&gt;Pagină nouă: Pagina dedicata companiei Milestone Pharmaceuticals Inc. listata cu simbolul US.MIST  ==Descriere companie== Milestone Pharmaceuticals Inc. (https://milestonepharma.com/) is a biopharmaceutical company. The Company is focused on the development and commercialization of cardiovascular medicines. Milestone’s lead product candidate is etripamil. The etripamil is a novel, potent and short-acting calcium channel blocker that has been designed rapid-onset nasal spray, which is se...&lt;/p&gt;
&lt;p&gt;&lt;b&gt;Pagină nouă&lt;/b&gt;&lt;/p&gt;&lt;div&gt;Pagina dedicata companiei Milestone Pharmaceuticals Inc. listata cu simbolul US.MIST&lt;br /&gt;
&lt;br /&gt;
==Descriere companie==&lt;br /&gt;
Milestone Pharmaceuticals Inc. (https://milestonepharma.com/) is a biopharmaceutical company. The Company is focused on the development and commercialization of cardiovascular medicines. Milestone’s lead product candidate is etripamil. The etripamil is a novel, potent and short-acting calcium channel blocker that has been designed rapid-onset nasal spray, which is self-administered by patients. The Company is developing etripamil to treat paroxysmal supraventricular tachycardia (PSVT), atrial fibrillation (AF) and rapid ventricular rate, and other cardiovascular indications.&lt;br /&gt;
&lt;br /&gt;
==Grafic actiuni companie==&lt;br /&gt;
&amp;lt;iframe key=&amp;quot;tradeville&amp;quot; path=&amp;quot;graficSimbol/US.MIST&amp;quot; /&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Ultimele stiri despre Milestone Pharmaceuticals Inc. (US.MIST)==&lt;br /&gt;
&amp;lt;dynamicpagelist&amp;gt;&lt;br /&gt;
category=US.MIST&lt;br /&gt;
count=10&lt;br /&gt;
order=descending&lt;br /&gt;
addfirstcategorydate=false&lt;br /&gt;
&amp;lt;/dynamicpagelist&amp;gt;&lt;br /&gt;
&lt;br /&gt;
[[Categorie:US.MIST]][[Categorie:Stiri despre companii]]&lt;/div&gt;</summary>
		<author><name>Admin</name></author>
	</entry>
</feed>